Merck Loses Bid To Toss 24 Fosamax Cases
A judge in charge of multidistrict litigation over Merck & Co. Inc.'s Fosamax has denied the drugmaker's motion to dismiss 24 cases that alleged the osteoporosis drug could cause jaw damage...To view the full article, register now.
Already a subscriber? Click here to view full article